Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Simple Search

Search Type: Criteria:

You could also try: mistake (35), fault (22), slip (31)

Panitumumab (21 day) Ver 1.1

Description: Chemotherapy Protocol COLORECTAL CANCER PANITUMUMAB (21 day) This regimen may require funding and is an unlicensed dose Regimen Colorectal Cancer – Panitumumab
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Panitumumab21dayVer11.pdf

Fluorouracil Folinic Acid

Description: Chemotherapy Protocol COLORECTAL CANCER FLUOROURACIL and FOLINIC ACID (Modified de Gramont) Regimen • Colorectal Cancer– Fluorouracil and Folinic Acid (Modified de Gramont
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Fluorouracil-Folinic-Acid.pdf

ColorectalTrifluridineTipiricilVer1

Description: Chemotherapy Protocol Regimen COLORECTAL CANCER TRIFLURIDINE-TIPIRACIL  Colorectal Cancer – Trifluridine-Tipiracil Indication  Trifluridine-tipiracil is recommended as a third or subsequent
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/ColorectalTrifluridineTipiricilVer1.pdf

Cetuximab-Fluorouracil-Folinic Acid-Oxaliplatin

Description: Chemotherapy Protocol COLORECTAL CANCER CETUXIMAB-FLUOROURACIL-FOLINIC ACID (Modified de Gramont)OXALIPLATIN Regimen • Colorectal Cancer – Cetuximab-Fluorouracil-Folinic Acid (modified de
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Cetuximab-Fluorouracil-FolinicAcid-Oxaliplatin.pdf

Temozolomide (200)

Description: Chemotherapy Protocol Central Nervous System TEMOZOLOMIDE (200) Regimen • CNS – Temozolomide (200) Indication • Recurrent or progressive malignant glioblastoma multiforme in patients not
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CNS/Temozolomide-200.pdf

Patients value candour

Description: Since the Mid Staffs inquiry in 2013, two distinct species of candour have emerged.
Url: /HealthProfessionals/Clinical-law-updates/Patients-value-candour.aspx

Nasogastric tubes: a narrow dispute

Description: Mr W, a 77 year old man with end stage dementia, lacked capacity to make decisions about his treatment.
Url: /HealthProfessionals/Clinical-law-updates/Nasogastric-tubes-a-narrow-dispute.aspx

UHS NHS FT Electronic Data Management System Access for External Monitors and Regulators for Research for email

Description: Department of Research and Development University Hospital Southampton NHS Foundation Trust C Level West Wing, Mailpoint 218 Southampton SO
Url: /Media/Southampton-Clinical-Research/BRC-CRF-templates/UHS-NHS-FT-Electronic-Data-Management-System-Access-for-External-Monitors-and-Regulators-for-Research-for-email.pdf

InP-Etoposide-Ifosfamide (3 day) v2

Description: Chemotherapy Protocol SARCOMA ETOPOSIDE-IFOSFAMIDE (3 day) Inpatient Regimen Regimen • Sarcoma-InP-Etoposide-Ifosfamide (3 day) Indication • Second line treatment of
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Sarcoma/InP-Etoposide-Ifosfamide-3-day-v2.pdf

Gemcitabine-Paclitaxel Albumin Bound (Abraxane)

Description: Chemotherapy Protocol PANCREATIC CANCER GEMCITABINE-PACLITAXEL ALBUMIN BOUND Regimen • Pancreatic Cancer – Gemcitabine-Paclitaxel Albumin Bound Indication • First line treatment of adult
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Pancreas/Gemcitabine-Paclitaxel-Albumin-Bound-Abraxane-Ver2.pdf

111 to 120 of 630

Previous … 10 11 12 13 14 … Next